![]()
Mycoplasma Test Kit Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Mycoplasma Test Kit market is projected to reach a size of approximately $450 million by 2027, driven by increasing prevalence of mycoplasma infections in research laboratories and biopharmaceutical companies. The market research reports highlight the growing demand for accurate and efficient testing solutions to prevent contamination issues.
Sample Report
◍ Zhejiang Kangte Biotechnology Co., Ltd.
◍ Fujirebio, Inc.
◍ Bioscience (Tianjin) Diagnostic Technology Co.,Ltd
◍ Sichuan Xincheng Biological
The competitive landscape of the Mycoplasma Test Kit market includes key players such as Zhejiang Kangte Biotechnology Co., Ltd., Fujirebio, Inc., Bioscience (Tianjin) Diagnostic Technology Co., Ltd, and others. These companies offer innovative testing solutions to aid in the detection of Mycoplasma infections, contributing to market growth.
◍ Xiamen Biotime Biotechnology Co., Ltd.
◍ Guangzhou KOFA Biotechnology Co.,Ltd.
◍ Getein Biotech
◍ OptiBio Co., Ltd.
◍ Shenzhen Kindmay Medical Co.,Ltd.
◍ Jinan Babio Biotech
- Zhejiang Kangte Biotechnology Co., Ltd. reported sales revenue of $50 million
- Bioscience (Tianjin) Diagnostic Technology Co., Ltd. reported sales revenue of $30 million
- Fujirebio, Inc. reported sales revenue of $80 million.
◍ Tianjin Yuehekang Biotechnology Co., Ltd.
◍ Eurolyser Diagnostica
◍ BIOMERICA
◍ Boditech Med Inc.
◍ Wuhan Aidikang Biotechnology Co., Ltd.
Request Sample Report
Hospital
Clinic
Pharmacy
Others
Request Sample Report
Human Mycoplasma
Animal Mycoplasma
$ 4.00 Billion
Request Sample Report